Utilize este identificador para referenciar este registo: https://hdl.handle.net/1822/74002

TítuloMetal ionzeolite materials against resistant bacteria, MRSA
Autor(es)Peixoto, Patrícia
Guedes, Joana F.
Rombi, Elisabetta
Fonseca, António
Almeida Aguiar, Cristina
Neves, Isabel C.
Data24-Ago-2021
EditoraAmerican Chemical Society
RevistaIndustrial & Engineering Chemistry Research
CitaçãoPeixoto, Patrícia; Guedes, Joana F.; Rombi, Elisabetta; Fonseca, António; Aguiar, Cristina; Neves, Isabel C., Metal ionzeolite materials against resistant bacteria, MRSA. Industrial & Engineering Chemistry Research, 60(35), 12883-12892, 2021
Resumo(s)Metal ionzeolite materials based on different zeolite structuresFAU (NaY, 100750 nm), LTA (4400 nm), and MFI (ZSM5, >100, 760, and 2500 nm) were studied for developing antimicrobial agents using a simple method. These zeolite structures were loaded with silver, copper, or zinc ions using an ion-exchange method and tested for antimicrobial activity against three bacteriaEscherichia coli, methicillin-sensitive Staphylococcus aureus, and methicillin-resistant Staphylococcus aureus (MRSA), a clinical isolate. Sample characterization confirmed the presence of metal ions and the stability of the zeolite structures. All mono- and bimetallic ionzeolite materials loaded with silver displayed higher antimicrobial activity than zinc- or copper-containing samples. The inhibitory effect of metal ionzeolite materials was even higher than the action of antibiotics, especially against MRSA. These findings show that silver ionzeolite materials have potential applications to combat bacterial infections and further prevent the prevalence of resistant microorganisms. The antimicrobial activity seems to be related to the acidity and Si/Al ratio of zeolites, according to the following scale: MFI > FAU > LTA. Particularly, the inhibitory effect against MRSA is a very promising result considering the difficulty of effective eradication of this resistant strain, the principal agent of nosocomial or healthcare-associated infections, which affect 3.2\% of all hospitalized patients in the United States and 6.5\% in the European Union.
TipoArtigo
URIhttps://hdl.handle.net/1822/74002
DOI10.1021/acs.iecr.1c01736
ISSN0888-5885
Versão da editorahttps://pubs.acs.org/doi/10.1021/acs.iecr.1c01736
Arbitragem científicayes
AcessoAcesso restrito UMinho
Aparece nas coleções:CEB - Publicações em Revistas/Séries Internacionais / Publications in International Journals/Series
CBMA - Artigos/Papers
CDQuim - Artigos (Papers)
DBio - Artigos/Papers

Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato 
document_54594_1.pdf
Acesso restrito!
5,66 MBAdobe PDFVer/Abrir

Partilhe no FacebookPartilhe no TwitterPartilhe no DeliciousPartilhe no LinkedInPartilhe no DiggAdicionar ao Google BookmarksPartilhe no MySpacePartilhe no Orkut
Exporte no formato BibTex mendeley Exporte no formato Endnote Adicione ao seu ORCID